PAR
Click for more information
4.17% 23.0¢ paradigm biopharmaceuticals limited..

I am just going thru the slides and comparing the data against...

  1. edgck
    1,705 Posts.
    lightbulb Created with Sketch. 114
    clock Created with Sketch.
    02/03/21
    07:51
    Post #: 51437220
    I am just going thru the slides and comparing the data against my winners.

    I am also assuming their target is Osteoarthritis which has a market of 9 billion in the last slide. Let me know if this is incorrect.
    PAR Price at posting: $2.34 Sentiment: None Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

UNT UNITH hard launching AI 'digital human' platform too 600+ companies as AI thematic survives sell-off
right-arrow Created with Sketch.
NEWS Good habits matters when it comes to finances
right-arrow Created with Sketch.
SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
SUM Summit Minerals jumps 6% as LiDAR survey boosts confidence in niobium mineralisation
right-arrow Created with Sketch.
WR1 Stock watchers charged up by Winsome Resources' latest lithium drilling results
right-arrow Created with Sketch.
NOX Noxopharm aims for autoimmune market with first human trial of SOF-SKN
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.0¢ 		Change
-0.010(4.17%) 		Mkt cap ! $80.45M
Open High Low Value Volume
24.5¢ 24.5¢ 23.0¢ $114.2K 478.8K

Buyers (Bids)

No. Vol. Price($)
9 185592 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 45500 1
View Market Depth
Last trade - 16.10pm 22/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.